This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (432)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in JAMA  Topic Collections  • Pediatrics  • Adolescent Medicine  • Psychiatry  • Attention Deficit Hyperactivity Disorder  • Alert me on articles by topic  Social Bookmarking   What's this?

Larry S. Goldman, MD; Myron Genel, MD; Rebecca J. Bezman, MD; Priscilla J. Slanetz, MD, MPH; for the Council on Scientific Affairs, American Medical Association

JAMA. 1998;279:1100-1107.

Objective.— To deal with public and professional concern regarding possible overprescription of attention-deficit/hyperactivity disorder (ADHD) medications, particularly methylphenidate, by reviewing issues related to the diagnosis, optimal treatment, and actual care of ADHD patients and of evidence of patient misuse of ADHD medications.

Data Sources.— Literature review using a National Library of Medicine database search for 1975 through March 1997 on the terms attention deficit disorder with hyperactivity,methylphenidate, stimulants, and stimulant abuse and dependence. Relevant documents from the Drug Enforcement Administration were also reviewed.

Study Selection.— All English-language studies dealing with children of elementary school through high school age were included.

Data Extraction.— All searched articles were selected and were made available to coauthors for review. Additional articles known to coauthors were added to the initial list, and a consensus was developed among the coauthors regarding the articles most pertinent to the issues requested in the resolution calling for this report. Relevant information from these articles was included in the report.

Data Synthesis.— Diagnostic criteria for ADHD are based on extensive empirical research and, if applied appropriately, lead to the diagnosis of a syndrome with high interrater reliability, good face validity, and high predictability of course and medication responsiveness. The criteria of what constitutes ADHD in children have broadened, and there is a growing appreciation of the persistence of ADHD into adolescence and adulthood. As a result, more children (especially girls), adolescents, and adults are being diagnosed and treated with stimulant medication, and children are being treated for longer periods of time. Epidemiologic studies using standardized diagnostic criteria suggest that 3% to 6% of the school-aged population (elementary through high school) may suffer from ADHD, although the percentage of US youth being treated for ADHD is at most at the lower end of this prevalence range. Pharmacotherapy, particularly use of stimulants, has been extensively studied and generally provides significant short-term symptomatic and academic improvement. There is little evidence that stimulant abuse or diversion is currently a major problem, particularly among those with ADHD, although recent trends suggest that this could increase with the expanding production and use of stimulants.

Conclusions.— Although some children are being diagnosed as having ADHD with insufficient evaluation and in some cases stimulant medication is prescribed when treatment alternatives exist, there is little evidence of widespread overdiagnosis or misdiagnosis of ADHD or of widespread overprescription of methylphenidate by physicians.

From the Council on Scientific Affairs, American Medical Association, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Treatment of Attention-Deficit/Hyperactivity Disorder
Fred A. Baughman, Jr, Peter R. Breggin, John H. Halpern, Larry S. Goldman, and Myron Genel
JAMA. 1999;281(16):1490-1491.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers
Jasinski and Krishnan
J Psychopharmacol 2009;23:410-418.
ABSTRACT  

A Comparison of Cognitive and Psychosocial Function for Males Within the ADHD Continuum
Padolsky
Clinical Case Studies 2008;7:521-537.
ABSTRACT  

Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD: Final Report of a 4-Year Study
Adler et al.
J Atten Disord 2008;12:248-253.
ABSTRACT  

ADHD Symptoms and Associated Psychopathology in a Community Sample of Adolescents From the European North of Russia
Ruchkin et al.
J Atten Disord 2008;12:54-63.
ABSTRACT  

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Focus 2008;6:401-426.
ABSTRACT | FULL TEXT  

Screening for Drug Abuse Among Medical and Nonmedical Users of Prescription Drugs in a Probability Sample of College Students
McCabe
Arch Pediatr Adolesc Med 2008;162:225-231.
ABSTRACT | FULL TEXT  

Relative Bioavailability of Lisdexamfetamine 70-mg Capsules in Fasted and Fed Healthy Adult Volunteers and in Solution: A Single-Dose, Crossover Pharmacokinetic Study
Krishnan and Zhang
J Clin Pharmacol 2008;48:293-302.
ABSTRACT | FULL TEXT  

Treating Attention-Deficit/Hyperactivity Disorder With a Stimulant Transdermal Patch: The Clinical Art
Arnold et al.
Pediatrics 2007;120:1100-1106.
ABSTRACT | FULL TEXT  

Can We Turn a Toxin Into a Tonic? Toward 21st-Century Television Alchemy
Christakis
Pediatrics 2007;120:647-648.
FULL TEXT  

Invited commentary: persistent organic pollutants and childhood learning and behavioural disorders
Korrick and Bellinger
J. Epidemiol. Community Health 2007;61:564-565.
FULL TEXT  

Measuring Outcomes in Attention-Deficit/Hyperactivity Disorder
Brown and Perrin
J Pediatr Psychol 2007;32:627-630.
FULL TEXT  

Attention-Deficit/Hyperactivity Disorder: Diagnosis, Lifespan, Comorbidities, and Neurobiology
Spencer et al.
J Pediatr Psychol 2007;32:631-642.
ABSTRACT | FULL TEXT  

ADHD Service Use Patterns in Youth
Leslie and Wolraich
J Pediatr Psychol 2007;32:695-710.
ABSTRACT | FULL TEXT  

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
Polanczyk et al.
Am. J. Psychiatry 2007;164:942-948.
ABSTRACT | FULL TEXT  

Stigmatizing Attitudes and Beliefs About Treatment and Psychiatric Medications for Children With Mental Illness
Pescosolido et al.
Psychiatr. Serv. 2007;58:613-618.
ABSTRACT | FULL TEXT  

Public Knowledge, Beliefs, and Treatment Preferences Concerning Attention-Deficit Hyperactivity Disorder
McLeod et al.
Psychiatr. Serv. 2007;58:626-631.
ABSTRACT | FULL TEXT  

Service innovation: transitional attention-deficit hyperactivity disorder clinic
Verity and Coates
Psychiatr. Bull. 2007;31:99-100.
FULL TEXT  

Association of the Adrenergic {alpha}2A Receptor Gene With Methylphenidate Improvement of Inattentive Symptoms in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Polanczyk et al.
Arch Gen Psychiatry 2007;64:218-224.
ABSTRACT | FULL TEXT  

Caregiver Depression and Medication Use by Youths With ADHD Who Receive Services in the Public Sector
Leslie et al.
Psychiatr. Serv. 2007;58:131-134.
ABSTRACT | FULL TEXT  

Stimulants and Sudden Death: What Is a Physician to Do?
Wilens et al.
Pediatrics 2006;118:1215-1219.
ABSTRACT | FULL TEXT  

Hippocampus and Amygdala Morphology in Attention-Deficit/Hyperactivity Disorder.
Plessen et al.
Arch Gen Psychiatry 2006;63:795-807.
ABSTRACT | FULL TEXT  

Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder
Gibson et al.
The Annals of Pharmacotherapy 2006;40:1134-1142.
ABSTRACT | FULL TEXT  

A comparison of preferred treatment outcomes between children with ADHD and their parents.
Traywick et al.
J Atten Disord 2006;9:590-597.
ABSTRACT  

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
Allen et al.
Neurology 2005;65:1941-1949.
ABSTRACT | FULL TEXT  

Prevalence and Correlates of ADHD Symptoms in the National Health Interview Survey
Cuffe et al.
J Atten Disord 2005;9:392-401.
ABSTRACT  

Assessment of ADHD: Differences Across Psychology Specialty Areas
Handler and DuPaul
J Atten Disord 2005;9:402-412.
ABSTRACT  

Association Between Smoking and Attention-Deficit/Hyperactivity Disorder Symptoms in a Population-Based Sample of Young Adults
Kollins et al.
Arch Gen Psychiatry 2005;62:1142-1147.
ABSTRACT | FULL TEXT  

Fragmented Care for Inner-City Minority Children With Attention-Deficit/Hyperactivity Disorder
Guevara et al.
Pediatrics 2005;116:e512-e517.
ABSTRACT | FULL TEXT  

The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD
Biederman et al.
Arch. Dis. Child. 2005;90:1010-1015.
ABSTRACT | FULL TEXT  

Myocardial infarction in an adolescent taking Adderall
Gandhi et al.
Am J Health Syst Pharm 2005;62:1494-1497.
FULL TEXT  

A 3-Year Panel Study of Mental Disorders Among Adolescents in Taiwan
Gau et al.
Am. J. Psychiatry 2005;162:1344-1350.
ABSTRACT | FULL TEXT  

Continuity of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder
Marcus et al.
Arch Pediatr Adolesc Med 2005;159:572-578.
ABSTRACT | FULL TEXT  

Use of the Conners-Wells Adolescent Self-Report Scale (Short Form) with Children
Parker et al.
J Atten Disord 2005;8:188-194.
ABSTRACT  

Trends in Diagnosis Rates for Autism and ADHD at Hospital Discharge in the Context of Other Psychiatric Diagnoses
Mandell et al.
Psychiatr. Serv. 2005;56:56-62.
ABSTRACT | FULL TEXT  

Efficacy and safety of atomoxetine in childhood Attention-Deficit/Hyperactivity Disorder with comorbid Oppositional Defiant Disorder
Kaplan et al.
J Atten Disord 2004;8:45-52.
ABSTRACT  

Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Greenhill et al.
Focus 2004;2:642-668.
ABSTRACT | FULL TEXT  

Sahaja Yoga Meditation as a Family Treatment Programme for Children with Attention Deficit-Hyperactivity Disorder
Harrison et al.
Clin Child Psychol Psychiatry 2004;9:479-497.
ABSTRACT  

Attention-Deficit/Hyperactivity Disorder in adult patients with Posttraumatic stress disorder (PTSD): Is ADHD a vulnerability factor?
Adler et al.
J Atten Disord 2004;8:11-16.
ABSTRACT  

A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)
Swanson et al.
Pediatrics 2004;113:e206-216.
ABSTRACT | FULL TEXT  

Social Representations of Attention Deficit/Hyperactivity Disorder, 1988-1997
Schmitz et al.
Culture Psychology 2003;9:383-406.
ABSTRACT  

A Dose-Response Study of OROS Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
Stein et al.
Pediatrics 2003;112:e404-404.
ABSTRACT | FULL TEXT  

National Trends in the Treatment of Attention Deficit Hyperactivity Disorder
Olfson et al.
Am. J. Psychiatry 2003;160:1071-1077.
ABSTRACT | FULL TEXT  

A qualitative study of Australian GPs' attitudes and practices in the diagnosis and management of attention-deficit/hyperactivity disorder (ADHD)
Shaw et al.
Fam Pract 2003;20:129-134.
ABSTRACT | FULL TEXT  

Latino Cultural Differences in Maternal Assessments of Attention Deficit/Hyperactivity Symptoms in Children
Schmitz and Velez
Hispanic Journal of Behavioral Sciences 2003;25:110-122.
ABSTRACT  

Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample
Cox et al.
Pediatrics 2003;111:237-243.
ABSTRACT | FULL TEXT  

Does the Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants Contribute to Drug Use/Abuse? A 13-Year Prospective Study
Barkley et al.
Pediatrics 2003;111:97-109.
ABSTRACT | FULL TEXT  

Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature
Wilens et al.
Pediatrics 2003;111:179-185.
ABSTRACT | FULL TEXT  

Psychotropic Medication Use in a Population of Children Who Have Attention-Deficit/Hyperactivity Disorder
Guevara et al.
Pediatrics 2002;109:733-739.
ABSTRACT | FULL TEXT  

Measuring Quality of Life in Children With Attention-deficit/Hyperactivity Disorder and Their Families: Development and Evaluation of a New Tool
Landgraf et al.
Arch Pediatr Adolesc Med 2002;156:384-391.
ABSTRACT | FULL TEXT  

Trends and Toxic Effects From Pediatric Clonidine Exposures
Klein-Schwartz
Arch Pediatr Adolesc Med 2002;156:392-396.
ABSTRACT | FULL TEXT  

An experimental comparison of Pycnogenol(R) and methylphenidate in adults with Attention-Deficit/ Hyperactivity Disorder (ADHD)
Tenenbaum et al.
J Atten Disord 2002;6:49-60.
ABSTRACT  

Sensitivity and Specificity of a Computerized Test of Attention in the Diagnosis of Attention-Deficit/Hyperactivity Disorder
Schatz et al.
Assessment 2001;8:357-365.
ABSTRACT  

Evidence based paediatrics: Evidence based management of attention deficit hyperactivity disorder
Guevara and Stein
BMJ 2001;323:1232-1235.
FULL TEXT  

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis
Schachter et al.
CMAJ 2001;165:1475-1488.
ABSTRACT | FULL TEXT  

Prescription of methylphenidate to children and youth, 1990-1996
Miller et al.
CMAJ 2001;165:1489-1494.
ABSTRACT | FULL TEXT  

Tourette's Syndrome
Jankovic
NEJM 2001;345:1184-1192.
FULL TEXT  

Attention-deficit hyperactivity disorder and the use of methylphenidate: A survey of the views of general practitioners
Ball
Psychiatr. Bull. 2001;25:301-304.
ABSTRACT | FULL TEXT  

Stimulant drugs for severe hyperactivity in childhood
DTB 2001;39:52-54.
ABSTRACT | FULL TEXT  

Utilization and Cost of Health Care Services for Children With Attention-Deficit/Hyperactivity Disorder
Guevara et al.
Pediatrics 2001;108:71-78.
ABSTRACT | FULL TEXT  

Once-a-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings
Pelham et al.
Pediatrics 2001;107:e105-105.
ABSTRACT | FULL TEXT  

Pediatric Stimulant and Selective Serotonin Reuptake Inhibitor Prescription Trends: 1992 to 1998
Rushton and Whitmire
Arch Pediatr Adolesc Med 2001;155:560-565.
ABSTRACT | FULL TEXT  

Current topic: An auditable protocol for treating attention deficit/hyperactivity disorder
Hill and Taylor
Arch. Dis. Child. 2001;84:404-409.
ABSTRACT | FULL TEXT  

The extent of drug therapy for ADHD among children in a large public school district
Goldstein and Turner
J Atten Disord 2001;4:212-219.
ABSTRACT  

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument
Faries et al.
J Atten Disord 2001;5:107-115.
ABSTRACT  

Attention Deficit Hyperactivity Disorder in Adults and Obstructive Sleep Apnea
Naseem et al.
Chest 2001;119:294-296.
ABSTRACT | FULL TEXT  

Placebo-Controlled Evaluation of Amphetamine Mixture{---}Dextroamphetamine Salts and Amphetamine Salts (Adderall): Efficacy Rate and Side Effects
Ahmann et al.
Pediatrics 2001;107:10e-10.
ABSTRACT | FULL TEXT  

Challenges to determining adolescent medication response in an outpatient clinical setting: Comparing Adderal and methylphenidate for ADHD
Barkley et al.
J Atten Disord 2000;4:102-113.
ABSTRACT  

Pediatrician and Family Physician Prescription of Selective Serotonin Reuptake Inhibitors
Rushton et al.
Pediatrics 2000;105:82e-82.
ABSTRACT | FULL TEXT  

Emotion appraisal in children with Attention-Deficit/Hyperactivity Disorder and their parents
Norvilitis et al.
J Atten Disord 2000;4:15-26.
ABSTRACT  

Caveat lector: be wary of media reports about excessive Ritalin use in BC
Dormuth et al.
CMAJ 2000;162:313-313.
FULL TEXT  

From the Editor
J Atten Disord 2000;3:173-191.
ABSTRACT  

A Comparison of Morning-Only and Morning/Late Afternoon Adderall to Morning-Only, Twice-Daily, and Three Times-Daily Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
Pelham et al.
Pediatrics 1999;104:1300-1311.
ABSTRACT | FULL TEXT  

Diagnosis of Attention-Deficit/Hyperactivity Disorder and Use of Psychotropic Medication in Very Young Children
Rappley et al.
Arch Pediatr Adolesc Med 1999;153:1039-1045.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman et al.
Pediatrics 1999;104:20e-20.
ABSTRACT | FULL TEXT  

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995
Robison et al.
CLIN PEDIATR 1999;38:209-217.
ABSTRACT  

Treatment of attention-deficit/hyperactivity disorder.
Baughman et al.
JAMA 1999;281:1490-1490.
FULL TEXT  

Evidence-based child psychiatry and the two solitudes
Szatmari
Evid. Based Ment. Health 1999;2:6-7.
FULL TEXT  

Attention Deficit/Hyperactivity Disorders
Miller and Castellanos
Pediatr. Rev. 1998;19:373-384.
FULL TEXT  

A 55-Year-Old Man With Attention-Deficit/Hyperactivity Disorder
Biederman
JAMA 1998;280:1086-1092.
FULL TEXT